Jane Street Group LLC Buys 7,126 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Jane Street Group LLC lifted its position in Semler Scientific, Inc. (NASDAQ:SMLR) by 72.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 16,982 shares of the company’s stock after purchasing an additional 7,126 shares during the period. Jane Street Group LLC owned about 0.23% of Semler Scientific worth $400,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. State Street Corp boosted its position in Semler Scientific by 0.6% during the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after buying an additional 725 shares during the period. Verition Fund Management LLC bought a new position in shares of Semler Scientific during the third quarter valued at about $251,000. Crawford Fund Management LLC purchased a new stake in shares of Semler Scientific during the third quarter worth about $883,000. Truvestments Capital LLC grew its stake in shares of Semler Scientific by 22.1% in the third quarter. Truvestments Capital LLC now owns 14,661 shares of the company’s stock worth $345,000 after purchasing an additional 2,654 shares during the last quarter. Finally, Cerity Partners LLC increased its holdings in Semler Scientific by 91.5% during the 3rd quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock valued at $31,689,000 after purchasing an additional 642,982 shares during the period. 49.37% of the stock is owned by hedge funds and other institutional investors.

Semler Scientific Stock Performance

NASDAQ SMLR opened at $55.24 on Wednesday. The stock has a market cap of $511.91 million, a P/E ratio of 26.95 and a beta of 1.18. Semler Scientific, Inc. has a fifty-two week low of $20.88 and a fifty-two week high of $81.56. The stock has a 50 day simple moving average of $55.94 and a two-hundred day simple moving average of $38.21.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. The company had revenue of $13.51 million during the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.